• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Polyrizon gets Nasdaq notice on Bid Requirements

    GLOBENEWSWIRE

    Polyrizon Hires Branding Firm for Brand Development

    GLOBENEWSWIRE

    Polyrizon Closes $17.0M Private Placement

    GLOBENEWSWIRE

    Polyrizon Ltd. Announces $17.0 Million Private Placement

    GLOBENEWSWIRE

    Polyrizon Plans Clinical Strategy For Allergy Blocker Before FDA

    GLOBENEWSWIRE

    Polyrizon Expands Drug Delivery With Preclinical Epilepsy Study

    GLOBENEWSWIRE

    Polyrizon Signs LOI to Expand Intranasal Delivery for Psychedelic

    GLOBENEWSWIRE

    Polyrizon Starts Preclinical Studies for Intranasal Naloxone

    GLOBENEWSWIRE

    Polyrizon Files Annual Report on Form 20-F for 2024

    GLOBENEWSWIRE

    Polyrizon Starts Preclinical Studies For Intranasal Naloxone

    GLOBENEWSWIRE

    Polyrizon Files Divisional Patent For Trap & Intranasal Platform

    GLOBENEWSWIRE

    Polyrizon Prepare GMP Manufacturing For PL-14 Allergy Blocker Trial

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.